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In this issue ofChemistry &Biology, Xie and colleagues describe a ‘‘phenotype directed’’ approach to identify
antibodies that protect cells from death caused by rhinovirus infection. The cellular antibody library of 108
clones yielded two antibodies that prevented cell death via the same viral target: rhinovirus 3C protease.Over the last two decades, recombinant
antibody selection technologies such as
phage and yeast display have provided
powerful methods to generate novel anti-
bodies. Using antibody display technolo-
gies, valuable functional antibodies have
been identified that interfere in cell
signaling by blocking or activating extra-
cellular receptor signaling. Such anti-
bodies are initially identified on the basis
of binding a target antigen before being
individually produced and tested in cell-
based functional assays.
The ready availability of antibody genes
using recombinant antibody approaches
opens up the possibility of combining anti-
body expression/production with func-
tional ‘‘reporting’’ within the same cell.
A number of recent publications have
described the identification of functional
antibodies based on this novel approach.
Antibody gene populations are introduced
into reporter cells, and clones within the
resulting population of cells with altered
phenotypes can be identified. It is then
relatively straightforward to recover the
antibody gene causing the modified
cellular behavior.
Typically, a molecular target is identi-
fied, and a target-specific antibody pop-
ulation is generated (e.g., from phage
display) and introduced into the reporter
cells (Figure 1, Target Directed). The re-
porter cells then allow identification or
selection of clones within the population
with an antibody-directed alteration in
phenotype (e.g., altered gene expression
or survival). To work efficiently, it is neces-
sary to have a method to introduce one or
a few antibody genes per cell (e.g., by len-
tiviral infection). It is also necessary for
the expressed antibody to be attached
or retained close to the cell producing it
to retain a linkage between phenotype
and genotype. This has been achieved
previously either through tethering the170 Chemistry & Biology 21, February 20, 201antibody to the cell surface or through
the use of semisolid medium to retain
secreted antibodies in the vicinity of pro-
ducing cells.
Through this approach, agonistic anti-
bodies targeted to the erythropoietin re-
ceptor, the thrombopoetin receptor, and
the GCSF receptor have been identified
using reporter cells transfected with the
target gene (Xie et al., 2013; Zhang
et al., 2012, 2013). In a related approach,
antibodies that neutralized FGF4 or
blocked its receptor FGFR1 were identi-
fied through regulated, secreted expres-
sion of antibody populations in mouse
embryonic stem cells (Melidoni et al.,
2013). Changes in differentiation out-
comes were identified using lineage-spe-
cific GFP expression.
In contrast to this ‘‘target-directed’’
approach, Xie et al. (2014); this issue
of Chemistry & Biology) have used an
approach that makes no assumptions
about the target antigen (Figure 1, Pheno-
type Directed). A similar nontargeted
approach has previously led to the iden-
tification of antibodies that activated in-
tegrin signaling through ‘‘RGD’’ sequence
motifs within their CDR regions (Yea et al.,
2013). The lack of a predefined target us-
ing the ‘‘phenotype-directed’’ approach
increases the level of difficulty and places
a greater requirement on achieving the
largest possible library. Xie et al. (2014)
used lentiviral infection to introduce an
unbiased antibody library into HeLa cells,
creating a cellular library of 108 clones.
Phenotypic selection for rare eventswithin
a large library requires a dominant pheno-
type for screening or selection, and there
is none better than selection for cell sur-
vival. In this case, antibodies were identi-
fied that imparted resistance to cell death
caused by rhinovirus infection.
In the work of Xie et al. (2014), anti-
bodies were expressed within the cyto-4 ª2014 Elsevier Ltd All rights reservedplasm, which not only ensures a close
linkage between ‘‘phenotype’’ and ‘‘geno-
type’’ within the same cell, but also opens
up a ‘‘universe’’ of intracellular targets.
Expression of antibodies within the cyto-
plasm, however, brings its own problems.
Only a small proportion of antibodies are
correctly folded in the reducing environ-
ment of the cytoplasm (Shaki-Loewen-
stein et al., 2005), so the ‘‘effective’’ library
size will be significantly less than the 108
clones created. The efficiency of this
approach could be enhanced using anti-
body frameworks or, indeed, other bind-
ing scaffolds that can fold effectively
in the reducing environment of the cyto-
plasm. Despite these potential limitations,
Xie et al. (2014) identified two different
antibodies that protected HeLa cells
from rhinovirus infection. This is impres-
sive, given the need for a highly effective
blockade of function within an antibody-
expressing cell clone against a backdrop
of rampant viral infection.
Having identified functional antibodies
by this ‘‘phenotype-directed’’ approach,
the target was identified as the rhinovirus
3C protein (using the antibodies for affinity
capture coupled to mass spectrometry).
3C protease is known to play an impor-
tant role in rhinoviral replication. The two
selected antibodies bound different epi-
topes of the 3C protease and appear
to operate by different mechanisms, with
only one of them directly affecting enzy-
matic activity in biochemical assays.
The ‘‘phenotype-directed’’ approach
uses a library of antibody genes to
knockout gene function at the protein
level. Development of genetic-based
methods for gene knockout, such as
the recently described CRISPR/Cas9
system, are progressing at a breath-
taking pace (Shalem et al., 2014; Wang
et al., 2014), and these can identify func-
tionally important genes with relative
Figure 1. Alternative Approaches to Identify
Functional Antibodies
‘‘Target-directed’’ approach depends on knowing
the identity of the target and introducing a prese-
lected population of binders into mammalian
reporter cells. ‘‘Phenotype-directed’’ approach,
employed by Xie et al. (2014), introduces a ‘‘naive’’
antibody population and selects desired antibody
clones based on the specific phenotype they elicit.
Target identification in this scheme is the final step
taken to resolve the antibody’s mechanism of
action.
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tant genes can also emerge from existing
knowledge of biological systems. In the
case of rhinovirus infection, it could be
argued that 3C protease as a targetwas predictable based on prior knowl-
edge of viral biology. Prior knowledge
of the role of a gene, however, doesn’t
necessarily highlight it as the ‘‘Achilles
heel’’ for targeting at the protein level.
In addition, functional knockout at the
protein level permits a more subtle inter-
vention than the “all or nothing” effect of
DNA based knock-outs. Thus, protein
knock-outs can act as a useful com-
plement to the increasingly efficient
DNA-based approaches. Furthermore,
the availability of functional antibodies
provides the potential for functional
knockdown in nongenetically modified
systems through exogenous addition of
antibody.
Although intracellular antibodies may
help identify points of biological interven-
tion, to date there are no examples of
antibody therapeutics directed to intra-
cellular targets, and extracellular recep-
tors and ligands remain the dominant
target class for therapeutic intervention.
Whether intracellular or extracellular pro-
teins are targeted, realizing the potential
of phenotype-directed selection schemes
requires construction of large mammalian
cell libraries combined with powerful
selection or reporting systems to identify
functional blockers or activators. In this
study, cell survival was used to identify
antibodies of interest. The develop-
ment of phenotype-directed approaches
to identify binder/target combinations
effecting changes in more subtle cellularChemistry & Biology 21, February 20, 2014responses remains a challenge. For
example, identification of antibodies that
cause cell death could identify targets
for antibody-directed therapies in areas
such as oncology. Thus, establishment
of creative cellular screens based on
parameters other than cell survival rep-
resents an important challenge and op-
portunity in target/drug discovery using
phenotypic-directed selection.
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